XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $367,000 | +619.6% | 150,107 | +1096.2% | 0.00% | – |
| Q2 2021 | $51,000 | -86.0% | 12,549 | -84.4% | 0.00% | – |
| Q1 2021 | $363,000 | -23.6% | 80,497 | -16.7% | 0.00% | -100.0% |
| Q4 2020 | $475,000 | +182.7% | 96,594 | +240.1% | 0.00% | – |
| Q3 2020 | $168,000 | – | 28,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|